Literature DB >> 19776747

p53--a Jack of all trades but master of none.

Melissa R Junttila1, Gerard I Evan.   

Abstract

Cancers are rare because their evolution is actively restrained by a range of tumour suppressors. Of these p53 seems unusually crucial as either it or its attendant upstream or downstream pathways are inactivated in virtually all cancers. p53 is an evolutionarily ancient coordinator of metazoan stress responses. Its role in tumour suppression is likely to be a relatively recent adaptation, which is only necessary when large, long-lived organisms acquired the sufficient size and somatic regenerative capacity to necessitate specific mechanisms to reign in rogue proliferating cells. However, such evolutionary reappropriation of this venerable transcription factor entails compromises that restrict its efficacy as a tumour suppressor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776747     DOI: 10.1038/nrc2728

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  88 in total

1.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  The ARF tumor suppressor can promote the progression of some tumors.

Authors:  Olivier Humbey; Julia Pimkina; Jack T Zilfou; Michal Jarnik; Carmen Dominguez-Brauer; Darren J Burgess; Christine M Eischen; Maureen E Murphy
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Complicating the role of p53 in aging.

Authors:  Amanda Gentry; Sundaresan Venkatachalam
Journal:  Aging Cell       Date:  2005-06       Impact factor: 9.304

4.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

7.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

9.  Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.

Authors:  Adam Gromley; Michelle L Churchman; Frederique Zindy; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-01       Impact factor: 11.205

10.  Polycomb CBX7 has a unifying role in cellular lifespan.

Authors:  Jesús Gil; David Bernard; Dolores Martínez; David Beach
Journal:  Nat Cell Biol       Date:  2003-11-30       Impact factor: 28.213

View more
  141 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.

Authors:  Anna E Vilgelm; Jeff S Pawlikowski; Yan Liu; Oriana E Hawkins; Tyler A Davis; Jessica Smith; Kevin P Weller; Linda W Horton; Colt M McClain; Gregory D Ayers; David C Turner; David C Essaka; Clinton F Stewart; Jeffrey A Sosman; Mark C Kelley; Jeffrey A Ecsedy; Jeffrey N Johnston; Ann Richmond
Journal:  Cancer Res       Date:  2014-11-14       Impact factor: 12.701

Review 4.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

5.  AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.

Authors:  Haitao Ji; Zhiyong Ding; David Hawke; Dongming Xing; Bing-Hua Jiang; Gordon B Mills; Zhimin Lu
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

6.  Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape.

Authors:  Courtney J Fleenor; Andriy Marusyk; James DeGregori
Journal:  Cell Cycle       Date:  2010-08-07       Impact factor: 4.534

7.  Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1.

Authors:  Isabel M Pires; Zuzana Bencokova; Chris McGurk; Ester M Hammond
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 8.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

9.  Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Sasidharan Padmaja Divya; Mei Xu; Jia Luo; Gang Chen; Zhuo Zhang; Xianglin Shi
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

10.  Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress.

Authors:  Jonathan Chang; Brandi N Davis-Dusenbery; Risa Kashima; Xuan Jiang; Nisha Marathe; Roberto Sessa; Justin Louie; Wei Gu; Giorgio Lagna; Akiko Hata
Journal:  EMBO J       Date:  2013-11-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.